| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020404004 |
| P356 | DOI | 10.1038/NATURE03912 |
| P3181 | OpenCitations bibliographic resource ID | 577288 |
| P698 | PubMed publication ID | 16121184 |
| P5875 | ResearchGate publication ID | 7639864 |
| P50 | author | S I Miller | Q69351500 |
| Michael J MacCoss | Q87441179 | ||
| P2093 | author name string | Lucas R Hoffman | |
| David A D'Argenio | |||
| Roger A Jones | |||
| Zhaoying Zhang | |||
| P2860 | cites work | Cell cycle-dependent dynamic localization of a bacterial response regulator with a novel di-guanylate cyclase output domain | Q24627219 |
| GGDEF and EAL domains inversely regulate cyclic di-GMP levels and transition from sessility to motility | Q27976509 | ||
| Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development | Q27976516 | ||
| A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance | Q28185783 | ||
| Comprehensive transposon mutant library of Pseudomonas aeruginosa | Q29614861 | ||
| Novel domains of the prokaryotic two-component signal transduction systems | Q29615334 | ||
| Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics | Q30874391 | ||
| FimX, a multidomain protein connecting environmental signals to twitching motility in Pseudomonas aeruginosa | Q34231850 | ||
| Cyclic di-GMP as a bacterial second messenger. | Q34338145 | ||
| Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa | Q35168460 | ||
| The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes | Q36602687 | ||
| Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. | Q37119379 | ||
| Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis | Q39475687 | ||
| Biofilm formation by hyperpiliated mutants of Pseudomonas aeruginosa | Q39739614 | ||
| Cyclic diguanylic acid and cellulose synthesis in Agrobacterium tumefaciens | Q39951165 | ||
| Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis | Q40682137 | ||
| Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis | Q40834016 | ||
| The phosphodiesterase activity of the HmsP EAL domain is required for negative regulation of biofilm formation in Yersinia pestis | Q41458177 | ||
| Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation | Q42674600 | ||
| Gene expression in Pseudomonas aeruginosa biofilms | Q43777487 | ||
| Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. | Q44254786 | ||
| A glutamate-alanine-leucine (EAL) domain protein of Salmonella controls bacterial survival in mice, antioxidant defence and killing of macrophages: role of cyclic diGMP. | Q46480554 | ||
| Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis | Q71605414 | ||
| The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis | Q72531292 | ||
| Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group | Q77760906 | ||
| P433 | issue | 7054 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibiotic | Q12187 |
| biofilm | Q467410 | ||
| P304 | page(s) | 1171-1175 | |
| P577 | publication date | 2005-08-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Aminoglycoside antibiotics induce bacterial biofilm formation | |
| P478 | volume | 436 |
| Q33645381 | A 96-well-plate-based optical method for the quantitative and qualitative evaluation of Pseudomonas aeruginosa biofilm formation and its application to susceptibility testing |
| Q37193423 | A Diguanylate Cyclase Acts as a Cell Division Inhibitor in a Two-Step Response to Reductive and Envelope Stresses |
| Q37209094 | A Novel Surface Structure Consisting of Contact-active Antibacterial Upper-layer and Antifouling Sub-layer Derived from Gemini Quaternary Ammonium Salt Polyurethanes |
| Q40460603 | A TolC-Like Protein of Actinobacillus pleuropneumoniae Is Involved in Antibiotic Resistance and Biofilm Formation. |
| Q64093344 | A Two-Step Strategy for the Rapid Enrichment of Nitrosocosmicus-Like Ammonia-Oxidizing Thaumarchaea |
| Q45126340 | A comparison of effects of broad-spectrum antibiotics and biosurfactants on established bacterial biofilms |
| Q36319174 | A cyclic-di-GMP receptor required for bacterial exopolysaccharide production |
| Q42691168 | A new environmentally resistant cell type from Dictyostelium |
| Q57154927 | A new tool to reveal bacterial signaling mechanisms in antibiotic treatment and resistance |
| Q40112398 | A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. |
| Q33673344 | A starvation-induced regulator, RovM, acts as a switch for planktonic/biofilm state transition in Yersinia pseudotuberculosis |
| Q38955424 | A tool named Iris for versatile high-throughput phenotyping in microorganisms. |
| Q42112385 | AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics |
| Q40936412 | Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms |
| Q102369430 | Advantages and limitations of microtiter biofilm assays in the model of antibiofilm activity of Klebsiella phage KP34 and its depolymerase |
| Q41856990 | Aerial exposure to the bacterial volatile compound trimethylamine modifies antibiotic resistance of physically separated bacteria by raising culture medium pH. |
| Q35660517 | Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin |
| Q34977352 | Aeromonas punctata derived depolymerase that disrupts the integrity of Klebsiella pneumoniae capsule: optimization of depolymerase production. |
| Q84984727 | AiiA quorum-sensing quenching controls proteolytic activity and biofilm formation by Enterobacter cloacae |
| Q35415063 | Alkaloids modulate motility, biofilm formation and antibiotic susceptibility of uropathogenic Escherichia coli |
| Q60938648 | Alterations of Liberibacter asiaticus-Associated Microbiota Decrease Survival of L. asiaticus in Assays |
| Q37760252 | An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal |
| Q28492942 | Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis-(3'-5')-cyclic-GMP in virulence |
| Q37711936 | Angucyclines as signals modulate the behaviors of Streptomyces coelicolor. |
| Q38694989 | Antagonistic Interactions and Biofilm Forming Capabilities Among Bacterial Strains Isolated from the Egg Surfaces of Lake Sturgeon (Acipenser fulvescens). |
| Q35890186 | Anti-Biofilm and Immunomodulatory Activities of Peptides That Inhibit Biofilms Formed by Pathogens Isolated from Cystic Fibrosis Patients |
| Q38841095 | Anti-adhesion activity of thyme (Thymus vulgaris L.) extract, thyme post-distillation waste, and olive (Olea europea L.) leaf extract against Campylobacter jejuni on polystyrene and intestine epithelial cells |
| Q37375370 | Anti-biofilm performance of three natural products against initial bacterial attachment |
| Q40209447 | Antibacterial Activity of 7-Epiclusianone and Its Novel Copper Metal Complex on Streptococcus spp. Isolated from Bovine Mastitis and Their Cytotoxicity in MAC-T Cells |
| Q93273414 | Antibacterial Effect of Cupral® on Oral Biofilms - An In-Vitro Study |
| Q42005688 | Antibacterial Properties of Flavonoids from Kino of the Eucalypt Tree, Corymbia torelliana. |
| Q42003861 | Antibacterial and antibiofilm activities of tryptoquivalines and meroditerpenes isolated from the marine-derived fungi Neosartorya paulistensis, N. laciniosa, N. tsunodae, and the soil fungi N. fischeri and N. siamensis |
| Q55395827 | Antibacterial and antibiofouling clay nanotube-silicone composite. |
| Q43090991 | Antibacterial efficacy of inhalable levofloxacin-loaded polymeric nanoparticles against E. coli biofilm cells: the effect of antibiotic release profile. |
| Q34313483 | Antibiofilm activity of Streptomyces sp. BFI 230 and Kribbella sp. BFI 1562 against Pseudomonas aeruginosa. |
| Q64083462 | Antibiotic Activity Potentiation and Physicochemical Characterization of the Fixed Almond Oil against MDR and Other Bacteria |
| Q52366252 | Antibiotic Stimulation of a Bacillus subtilis Migratory Response. |
| Q35101682 | Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii |
| Q42516402 | Antibiotic pretreatment minimizes dietary effects on reconstructure of rumen fluid and mucosal microbiota in goats. |
| Q37599031 | Antibiotic stress selects against cooperation in the pathogenic bacterium Pseudomonas aeruginosa |
| Q35194014 | Antibiotics as intermicrobial signaling agents instead of weapons |
| Q37904976 | Antibiotics as signal molecules. |
| Q36732540 | Antibiotics as signalling molecules |
| Q44678280 | Antibiotics at subinhibitory concentrations improve the quorum sensing behavior of Chromobacterium violaceum |
| Q40796010 | Antibodies directed against integration host factor mediate biofilm clearance from Nasopore |
| Q34680558 | Antibody-guided alpha radiation effectively damages fungal biofilms |
| Q47098465 | Antimicrobial Activity of Bee Venom and Melittin against Borrelia burgdorferi |
| Q39800487 | Antimicrobial Pressure of Ciprofloxacin and Gentamicin on Biofilm Development by an Endoscope-Isolated Pseudomonas aeruginosa |
| Q42751901 | Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria |
| Q42700440 | Antimicrobial and Antibiofilm Effects of Human Amniotic/Chorionic Membrane Extract on Streptococcus pneumoniae |
| Q36224086 | Antimicrobial chemokines |
| Q35591324 | Antimicrobial properties of Kalanchoe blossfeldiana: a focus on drug resistance with particular reference to quorum sensing-mediated bacterial biofilm formation |
| Q35230652 | Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis |
| Q38147863 | Applying insights from biofilm biology to drug development - can a new approach be developed? |
| Q58385927 | Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes |
| Q58735621 | Association Between Type, Virulence Factors, Biofilm Formation and Antibiotic Resistance of Isolates From Pork Production |
| Q90387791 | Association between gentamicin resistance and stress tolerance in water isolates of Ralstonia pickettii and R. mannitolilytica |
| Q37531699 | Asymmetrical distribution of the second messenger c-di-GMP upon bacterial cell division |
| Q43160311 | Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes |
| Q49129905 | AvaR2, a pseudo γ-butyrolactone receptor homologue from Streptomyces avermitilis, is a pleiotropic repressor of avermectin and avenolide biosynthesis and cell growth. |
| Q41588742 | AzaSite® inhibits Staphylococcus aureus and coagulase-negative Staphylococcus biofilm formation in vitro |
| Q90169719 | Bacterial Defense Systems against the Neutrophilic Oxidant Hypochlorous Acid |
| Q40521036 | Bacterial Hyaluronidase Self-Triggered Prodrug Release for Chemo-Photothermal Synergistic Treatment of Bacterial Infection |
| Q27008535 | Bacterial Responses and Genome Instability Induced by Subinhibitory Concentrations of Antibiotics |
| Q51037201 | Bacterial adaptation to sublethal antibiotic gradients can change the ecological properties of multitrophic microbial communities. |
| Q36315932 | Bacterial danger sensing |
| Q38371796 | Bacterial responses to antibiotics and their combinations |
| Q36147786 | Bactericidal, quorum quenching and anti-biofilm nanofactories: a new niche for nanotechnologists. |
| Q26745094 | Bacteriophages as Weapons Against Bacterial Biofilms in the Food Industry |
| Q37853657 | Bacteriophages for the treatment of Pseudomonas aeruginosa infections |
| Q38138178 | Bench-to-bedside review: Challenges of diagnosis, care and prevention of central catheter-related bloodstream infections in children |
| Q35203908 | Beta- lactam antibiotics stimulate biofilm formation in non-typeable haemophilus influenzae by up-regulating carbohydrate metabolism |
| Q38920223 | Beyond conventional antibiotics - New directions for combination products to combat biofilm |
| Q92407973 | Biofilm Bridges Forming Structural Networks on Patterned Lubricant-Infused Surfaces |
| Q35686917 | Biofilm Formation As a Response to Ecological Competition |
| Q64989991 | Biofilm Formation in Acinetobacter Baumannii: Genotype-Phenotype Correlation. |
| Q99235423 | Biofilm formation and extracellular microvesicles - the way of foodborne pathogens toward resistance |
| Q41956031 | Biofilm formation by Clostridium difficile. |
| Q35162817 | Biofilm formation of Clostridium perfringens and its exposure to low-dose antimicrobials |
| Q34261410 | Biofilm formation on biotic and abiotic surfaces in the presence of antimicrobials by Escherichia coli Isolates from cases of bovine mastitis |
| Q38048367 | Biofilm infections, their resilience to therapy and innovative treatment strategies |
| Q37291396 | Biofilm matrix and its regulation in Pseudomonas aeruginosa |
| Q38691962 | Biofilm-Induced Type 2 Innate Immunity in a Cystic Fibrosis Model of Pseudomonas aeruginosa. |
| Q41901656 | Biofilm-forming Staphylococcus epidermidis expressing vancomycin resistance early after adhesion to a metal surface. |
| Q30403958 | Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. |
| Q38041189 | Biofilm-specific antibiotic resistance |
| Q56080242 | Biofilms |
| Q28077424 | Biofilms and Cyclic di-GMP (c-di-GMP) Signaling: Lessons from Pseudomonas aeruginosa and Other Bacteria |
| Q38589676 | Biofilms and human health. |
| Q38796742 | Biofilms in ventilator-associated pneumonia |
| Q34413704 | Biofilms of a Bacillus subtilis hospital isolate protect Staphylococcus aureus from biocide action |
| Q54475630 | Biofilms strike back. |
| Q44861090 | Bismuth-ethanedithiol incorporated in a liposome-loaded tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa |
| Q90975666 | Breakdown of Vibrio cholerae biofilm architecture induced by antibiotics disrupts community barrier function |
| Q36217628 | Bypass of Candida albicans Filamentation/Biofilm Regulators through Diminished Expression of Protein Kinase Cak1. |
| Q36499446 | Calcium-chelating alizarin and other anthraquinones inhibit biofilm formation and the hemolytic activity of Staphylococcus aureus |
| Q58745077 | Cellular hysteresis as a principle to maximize the efficacy of antibiotic therapy |
| Q47448907 | Characterization of Three Ocular Clinical Isolates of P. aeruginosa: Viability, Biofilm Formation, Adherence, Infectivity, and Effects of Glycyrrhizin |
| Q33647967 | Chp8, a diguanylate cyclase from Pseudomonas syringae pv. Tomato DC3000, suppresses the pathogen-associated molecular pattern flagellin, increases extracellular polysaccharides, and promotes plant immune evasion |
| Q93051797 | Clinical Impact of Antibiotics for the Treatment of Pseudomonas aeruginosa Biofilm Infections |
| Q36672715 | Collateral effects of antibiotics: carbadox and metronidazole induce VSH-1 and facilitate gene transfer among Brachyspira hyodysenteriae strains |
| Q47258469 | Collismycin C from the Micronesian Marine Bacterium Streptomyces sp. MC025 Inhibits Staphylococcus aureus Biofilm Formation |
| Q46107780 | Combination Susceptibility Testing of Common Antimicrobials in Vitro and the Effects of Sub-MIC of Antimicrobials on Staphylococcus aureus Biofilm Formation |
| Q34710667 | Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells |
| Q30277949 | Comparative effectiveness of catheter salvage strategies for pediatric catheter-related bloodstream infections |
| Q46482802 | Competition sensing: the social side of bacterial stress responses |
| Q43245583 | Concentration-dependent activity of antibiotics in natural environments |
| Q36599009 | Contribution of bacillomycin D in Bacillus amyloliquefaciens SQR9 to antifungal activity and biofilm formation |
| Q43314267 | Control of biofilm formation in water using molecularly capped silver nanoparticles |
| Q50441547 | Coupling between the BLUF and EAL domains in the blue light-regulated phosphodiesterase BlrP1. |
| Q55514304 | Critical Assessment of Methods to Quantify Biofilm Growth and Evaluate Antibiofilm Activity of Host Defence Peptides. |
| Q54440632 | Critical role of the heme axial ligand, Met95, in locking catalysis of the phosphodiesterase from Escherichia coli (Ec DOS) toward Cyclic diGMP. |
| Q34518702 | Critique of the use of fluorescence-based reporters in Escherichia coli as a screening tool for the identification of peptide inhibitors of Aβ42 aggregation. |
| Q27649569 | Crystal structure of IcaR, a repressor of the TetR family implicated in biofilm formation in Staphylococcus epidermidis |
| Q91740943 | Current Status of In Vitro Models and Assays for Susceptibility Testing for Wound Biofilm Infections |
| Q38118107 | Cyclic di-AMP: another second messenger enters the fray |
| Q35220681 | Cyclic di-GMP signaling in bacteria: recent advances and new puzzles. |
| Q54561145 | Cyclic di-GMP signalling in the virulence and environmental adaptation of Xanthomonas campestris. |
| Q26850396 | Cyclic di-GMP: the first 25 years of a universal bacterial second messenger |
| Q58023653 | Cyclic-di-GMP levels affectPseudomonas aeruginosafitness in the presence of imipenem |
| Q36364631 | Defining Genetic Fitness Determinants and Creating Genomic Resources for an Oral Pathogen |
| Q34116324 | Depolymerase improves gentamicin efficacy during Klebsiella pneumoniae induced murine infection |
| Q46251510 | Design and synthesis of bis-carbamate analogs of cyclic bis-(3'-5')-diguanylic acid (c-di-GMP) and the acyclic dimer PGPG. |
| Q57896750 | Detergent-induced cell aggregation in subpopulations of Pseudomonas aeruginosa as a preadaptive survival strategy |
| Q37381385 | Development of a poly(ether urethane) system for the controlled release of two novel anti-biofilm agents based on gallium or zinc and its efficacy to prevent bacterial biofilm formation |
| Q28829570 | Development of an in vitro Assay, Based on the BioFilm Ring Test(®), for Rapid Profiling of Biofilm-Growing Bacteria |
| Q37139191 | Development of quorum-based anti-virulence therapeutics targeting Gram-negative bacterial pathogens |
| Q35012316 | Discovery and biological characterization of the auromomycin chromophore as an inhibitor of biofilm formation in Vibrio cholerae |
| Q24684087 | Dispersing biofilms with engineered enzymatic bacteriophage |
| Q91707704 | Diversity, Ecology, and Prevalence of Antimicrobials in Nature |
| Q89866468 | Droplet-based digital antibiotic susceptibility screen reveals single-cell clonal heteroresistance in an isogenic bacterial population |
| Q57146116 | Ecology determines how low antibiotic concentration impacts community composition and horizontal transfer of resistance genes |
| Q33417531 | Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions |
| Q47680880 | Effect of antibiotic prophylaxis on Coagulase-negative Staphylococcus virulence factor profiles in patients undergoing cataract surgery |
| Q33914789 | Effect of electrical energy on the efficacy of biofilm treatment using the bioelectric effect |
| Q39093585 | Effects of Actinomycete Secondary Metabolites on Sediment Microbial Communities |
| Q43189616 | Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa |
| Q89535880 | Effects of biotic and abiotic factors on biofilm growth dynamics and their heterogeneous response to antibiotic challenge |
| Q54584789 | Effects of chronic sub-lethal oxidative stress on biofilm formation by Azotobacter vinelandii. |
| Q90160105 | Effects of exogenous glucose on Pseudomonas aeruginosa biofilm formation and antibiotic resistance |
| Q90212789 | Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice |
| Q42421195 | Efficacy of the combination of tobramycin and a macrolide in an in vitro Pseudomonas aeruginosa mature biofilm model |
| Q33876518 | Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and -negative clinical isolates of Staphylococcus epidermidis. |
| Q33897944 | Environmental bacteriophages active on biofilms and planktonic forms of toxigenic Vibrio cholerae: Potential relevance in cholera epidemiology |
| Q46397704 | Environmental fluctuation governs selection for plasticity in biofilm production |
| Q90713544 | Environmental stress perception activates structural remodeling of extant Streptococcus mutans biofilms |
| Q39450212 | Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa. |
| Q39506059 | Evaluation of Different Phenotypic Techniques for the Detection of Slime Produced by Bacteria Isolated from Clinical Specimens |
| Q44531141 | Evaluation of biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro |
| Q52578140 | Evaluation of the in vivo efficacy of topical tobramycin against Pseudomonas sinonasal biofilms. |
| Q38211644 | Evolution and impact of bacterial drug resistance in the context of cystic fibrosis disease and nosocomial settings |
| Q38160197 | Evolution of resistance to quorum-sensing inhibitors. |
| Q36576233 | Evolutionary consequences of antibiotic use for the resistome, mobilome and microbial pangenome |
| Q39544046 | Evolutionary dynamics of separate and combined exposure of Pseudomonas fluorescens SBW25 to antibiotics and bacteriophage |
| Q83227516 | Evolutionary pathways to antibiotic resistance are dependent upon environmental structure and bacterial lifestyle |
| Q35537281 | Exhaled nitric oxide in sarcoidosis |
| Q40622669 | Exopolysaccharide biosynthetic glycoside hydrolases can be utilized to disrupt and prevent Pseudomonas aeruginosa biofilms. |
| Q42738228 | Exploratory study of the prevalence and clinical significance of tobramycin-mediated biofilm induction in Pseudomonas aeruginosa isolates from cystic fibrosis patients |
| Q58077490 | Exploring the Links Between Nucleotide Signaling and Quorum Sensing Pathways in Regulating Bacterial Virulence |
| Q64281245 | Extracellular DNA release, quorum sensing, and PrrF1/F2 small RNAs are key players in Pseudomonas aeruginosa tobramycin-enhanced biofilm formation |
| Q97883376 | Extracellular Vesicles Influence the Growth and Adhesion of Staphylococcus epidermidis Under Antimicrobial Selective Pressure |
| Q34096987 | Extracellular protease in Actinomycetes culture supernatants inhibits and detaches Staphylococcus aureus biofilm formation |
| Q37633817 | Ferromagnetic nanoparticles with peroxidase-like activity enhance the cleavage of biological macromolecules for biofilm elimination |
| Q34058108 | Fitness landscape of antibiotic tolerance in Pseudomonas aeruginosa biofilms |
| Q35657030 | Flushing and Locking of Venous Catheters: Available Evidence and Evidence Deficit |
| Q50016493 | Formation of biofilms under phage predation: considerations concerning a biofilm increase. |
| Q28492883 | FppA, a novel Pseudomonas aeruginosa prepilin peptidase involved in assembly of type IVb pili |
| Q30424697 | From in vitro to in vivo Models of Bacterial Biofilm-Related Infections. |
| Q90603077 | Functional characterization of a novel arachidonic acid 12S-lipoxygenase in the halotolerant bacterium Myxococcus fulvus exhibiting complex social living patterns |
| Q54468515 | Functional classification of drugs by properties of their pairwise interactions. |
| Q33372102 | Gene-boosted assembly of a novel bacterial genome from very short reads |
| Q29615301 | Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients |
| Q64904151 | Genomic analyses of two novel biofilm-degrading methicillin-resistant Staphylococcus aureus phages. |
| Q34031581 | Genomic interplay in bacterial communities: implications for growth promoting practices in animal husbandry. |
| Q35636397 | Gentamicin promotes Staphylococcus aureus biofilms on silk suture |
| Q24657841 | Get the message out: cyclic-Di-GMP regulates multiple levels of flagellum-based motility |
| Q28533869 | Ginger extract inhibits biofilm formation by Pseudomonas aeruginosa PA14 |
| Q34591603 | Global transcriptional responses to the bacteriocin colicin M in Escherichia coli |
| Q33520358 | Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii |
| Q35550444 | Growth promotion and gut microbiota: insights from antibiotic use. |
| Q37474874 | Halogenated indoles eradicate bacterial persister cells and biofilms |
| Q59341066 | Harnessing Metabolic Regulation to Increase Hfq-Dependent Antibiotic Susceptibility in |
| Q46194643 | Helicobacter pylori free-living and biofilm modes of growth: behavior in response to different culture media |
| Q55400133 | Herring Oil and Omega Fatty Acids Inhibit Staphylococcus aureus Biofilm Formation and Virulence. |
| Q59813016 | Heterogeneous Colistin-Resistance Phenotypes Coexisting in Isolates Influence Colistin Susceptibility Testing |
| Q36291549 | Histologic, Molecular, and Clinical Evaluation of Explanted Breast Prostheses, Capsules, and Acellular Dermal Matrices for Bacteria |
| Q35132724 | Horizontal gene exchange in environmental microbiota |
| Q39189505 | Host cell contact induces expression of virulence factors and VieA, a cyclic di-GMP phosphodiesterase, in Vibrio cholerae |
| Q38289682 | Human host defense peptide LL-37 prevents bacterial biofilm formation |
| Q58609700 | Identification of Small Molecule Modulators of Diguanylate Cyclase by FRET-based High-Throughput-Screening |
| Q37544601 | Image-based 384-well high-throughput screening method for the discovery of skyllamycins A to C as biofilm inhibitors and inducers of biofilm detachment in Pseudomonas aeruginosa. |
| Q54268842 | Immobilized Hydrolytic Enzymes Exhibit Antibiofilm Activity Against Escherichia coli at Sub-Lethal Concentrations. |
| Q52631107 | Impact of nutritional stress on drug susceptibility and biofilm structures of Burkholderia pseudomallei and Burkholderia thailandensis grown in static and microfluidic systems. |
| Q58615996 | In Vitro Formation of Dickeya zeae MS1 Biofilm |
| Q40642439 | In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections |
| Q44148089 | In vitro effect of subinhibitory concentrations of antibiotics on biofilm formation by clinical strains of Salmonella enterica serovar Typhimurium isolated in Slovakia |
| Q48277615 | In vitro effect of subminimal inhibitory concentrations of antibiotics on the biofilm formation ability of Acinetobacter baumannii clinical isolates |
| Q42017846 | In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis |
| Q37697412 | In vivo Host Environment Alters Pseudomonas aeruginosa Susceptibility to Aminoglycoside Antibiotics |
| Q38667889 | Increased ParB level affects expression of stress response, adaptation and virulence operons and potentiates repression of promoters adjacent to the high affinity binding sites parS3 and parS4 in Pseudomonas aeruginosa |
| Q48462271 | Increased production of biofilms by Escherichia coli in the presence of enrofloxacin. |
| Q35671651 | Individual Constituents from Essential Oils Inhibit Biofilm Mass Production by Multi-Drug Resistant Staphylococcus aureus. |
| Q40149019 | Individual and Combined Effects of Engineered Peptides and Antibiotics on Pseudomonas aeruginosa Biofilms. |
| Q34139508 | Indole-3-acetaldehyde from Rhodococcus sp. BFI 332 inhibits Escherichia coli O157:H7 biofilm formation |
| Q37409852 | Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes |
| Q38941353 | Inflammatory properties of antibiotic-treated bacteria |
| Q47755759 | Influence of Excipients on the Antimicrobial Activity of Tobramycin Against Pseudomonas aeruginosa Biofilms |
| Q28386160 | Inhaled Antibiotics for Gram-Negative Respiratory Infections |
| Q38569772 | Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives |
| Q42725897 | Inhibition of Cell Differentiation in Bacillus subtilis by Pseudomonas protegens |
| Q49928748 | Inhibition of Initial Attachment of Injured Salmonella Typhimurium onto Abiotic Surfaces. |
| Q41569871 | Inhibition of Staphylococcus epidermidis biofilm by trimethylsilane plasma coating |
| Q34165875 | Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide |
| Q38435598 | Inhibitory effects of 4-hydroxy-2,5-dimethyl-3(2H)-furanone (HDMF) on acyl-homoserine lactone-mediated virulence factor production and biofilm formation in Pseudomonas aeruginosa PAO1. |
| Q91965313 | Insights into Antagonistic Interactions of Multidrug Resistant Bacteria in Mangrove Sediments from the South Indian State of Kerala |
| Q92764911 | Integron-Derived Aminoglycoside-Sensing Riboswitches Control Aminoglycoside Acetyltransferase Resistance Gene Expression |
| Q37126792 | Interbacterial signaling via Burkholderia contact-dependent growth inhibition system proteins |
| Q46276934 | Interplay between antibiotic efficacy and drug-induced lysis underlies enhanced biofilm formation at subinhibitory drug concentrations |
| Q36398963 | Interplay of antibiotics and bacterial inoculum on suture-associated biofilms |
| Q24673124 | Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa |
| Q42202818 | Is there a role for antimicrobial stewardship in cystic fibrosis? |
| Q37668225 | Jamming bacterial communication: new approaches for the treatment of infectious diseases |
| Q35143390 | Kin cell lysis is a danger signal that activates antibacterial pathways of Pseudomonas aeruginosa |
| Q94545305 | Lactonase Specificity Is Key to Quorum Quenching in Pseudomonas aeruginosa |
| Q36319468 | Laser-generated shockwaves enhance antibacterial activity against biofilms in vitro |
| Q38214155 | Liposomal antibiotic formulations for targeting the lungs in the treatment of Pseudomonas aeruginosa |
| Q40116694 | Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis |
| Q88336827 | Low-level concentrations of aminoglycoside antibiotics induce the aggregation of cyanobacteria |
| Q51526958 | Maternal and environmental effects on symbiont-mediated antimicrobial defense. |
| Q34764576 | Medical biofilms |
| Q35355041 | Microbes in the neonatal intensive care unit resemble those found in the gut of premature infants. |
| Q46781795 | Microbial interaction between a CTXM-15 -producing Escherichia coli and a susceptible Pseudomonas aeruginosa isolated from bronchoalveolar lavage: influence of cefotaxime in the dual-species biofilm formation |
| Q38114534 | Microbial persistence and the road to drug resistance |
| Q38214805 | Microbiological effects of sublethal levels of antibiotics. |
| Q41990626 | Microbiota of Chronic Diabetic Wounds: Ecology, Impact, and Potential for Innovative Treatment Strategies |
| Q57527650 | Modeling Biofilms in Water Systems with New Variables: A Review |
| Q46402561 | Modulation of secreted virulence factor genes by subinhibitory concentrations of antibiotics in Pseudomonas aeruginosa |
| Q33823434 | Monitoring surface chemical changes in the bacterial cell wall: multivariate analysis of cryo-x-ray photoelectron spectroscopy data |
| Q36035660 | Multifaceted Interfaces of Bacterial Competition. |
| Q36683593 | Multiple Pathways of Genome Plasticity Leading to Development of Antibiotic Resistance. |
| Q42958466 | Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile |
| Q34300263 | Mycobacterium avium ssp. hominissuis biofilm is composed of distinct phenotypes and influenced by the presence of antimicrobials |
| Q35198896 | N-terminally modified linear and branched spermine backbone dipeptidomimetics against planktonic and sessile methicillin-resistant Staphylococcus aureus |
| Q35155421 | NMR analysis of a stress response metabolic signaling network |
| Q39422574 | Natural-Product Antibiotics: Cues for Modulating Bacterial Biofilm Formation. |
| Q38766230 | Neofiscalin A and fiscalin C are potential novel indole alkaloid alternatives for the treatment of multidrug-resistant Gram-positive bacterial infections. |
| Q37804379 | New antimicrobial strategies in cystic fibrosis |
| Q43163267 | Nickel promotes biofilm formation by Escherichia coli K-12 strains that produce curli |
| Q37451442 | Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal |
| Q57036685 | Nitrosative stress inhibits production of the virulence factor alginate in mucoidPseudomonas aeruginosa |
| Q91811486 | Non-Lethal Effects of N-Acetylcysteine on Xylella fastidiosa Strain De Donno Biofilm Formation and Detachment |
| Q36301442 | Non-invasive determination of conjugative transfer of plasmids bearing antibiotic-resistance genes in biofilm-bound bacteria: effects of substrate loading and antibiotic selection |
| Q33726796 | Nonoptimal microbial response to antibiotics underlies suppressive drug interactions |
| Q42680076 | Novel drug targets in cell wall biosynthesis exploited by gene disruption in Pseudomonas aeruginosa. |
| Q38135743 | Novel strategies for the prevention and treatment of biofilm related infections |
| Q37395225 | Open Capsulotomy: An Effective but Overlooked Treatment for Capsular Contracture after Breast Augmentation |
| Q37695294 | Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains |
| Q55332362 | Overcoming antibiotic resistance in Pseudomonas aeruginosa biofilms using glycopeptide dendrimers. |
| Q54349657 | Palmitoyl-DL-carnitine is a multitarget inhibitor of Pseudomonas aeruginosa biofilm development. |
| Q37194636 | Pathogenic shifts in endogenous microbiota impede tissue regeneration via distinct activation of TAK1/MKK/p38 |
| Q40440920 | Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis. |
| Q38272180 | Penicillin acylases revisited: importance beyond their industrial utility |
| Q59798053 | Penile prosthesis biofilm formation and emerging therapies against them |
| Q38263995 | Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections |
| Q51144344 | Phage treatment of an aortic graft infected with Pseudomonas aeruginosa. |
| Q37956403 | Pharmacological considerations for the proper clinical use of aminoglycosides |
| Q40524451 | Phenotype overlap in Xylella fastidiosa is controlled by the cyclic di-GMP phosphodiesterase Eal in response to antibiotic exposure and diffusible signal factor-mediated cell-cell signaling |
| Q38006032 | Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections |
| Q91809361 | Phenotypic Characterization of Rhodococcus equi Biofilm Grown In Vitro and Inhibiting and Dissolving Activity of Azithromycin/Rifampicin Treatment |
| Q38793893 | Phenotypic Resistance to Antibiotics. |
| Q89835058 | Plant Phenolics and Phenolic-Enriched Extracts as Antimicrobial Agents against Food-Contaminating Microorganisms |
| Q42529764 | Polymorphism of the signaling molecule c-di-GMP |
| Q34348146 | Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. |
| Q41641450 | Pseudomonas aeruginosa Genome Evolution in Patients and under the Hospital Environment |
| Q28493110 | Pseudomonas aeruginosa cupA-encoded fimbriae expression is regulated by a GGDEF and EAL domain-dependent modulation of the intracellular level of cyclic diguanylate |
| Q40239225 | Pseudomonas aeruginosa-Derived Rhamnolipids and Other Detergents Modulate Colony Morphotype and Motility in the Burkholderia cepacia Complex |
| Q35084559 | Pseudomonas aeruginosa: resistance to the max |
| Q38844899 | Pseudomonas aeruginosa: targeting cell-wall metabolism for new antibacterial discovery and development |
| Q26829007 | Pseudomonas biofilms: possibilities of their control |
| Q35611478 | Pyrrolnitrin and Hydrogen Cyanide Production by Pseudomonas chlororaphis Strain PA23 Exhibits Nematicidal and Repellent Activity against Caenorhabditis elegans |
| Q37232492 | Quorum-sensing control of antibiotic synthesis in Burkholderia thailandensis |
| Q26823282 | Reactive oxygen species, apoptosis, antimicrobial peptides and human inflammatory diseases |
| Q39144677 | Real Time, Spatial, and Temporal Mapping of the Distribution of c-di-GMP during Biofilm Development |
| Q36228997 | Reduced Staphylococcus aureus biofilm formation in the presence of chitosan-coated iron oxide nanoparticles |
| Q37425271 | Regulation of c-di-GMP metabolism in biofilms |
| Q37934486 | Regulation of growth and death in Escherichia coli by toxin-antitoxin systems. |
| Q35331333 | Relation between antibiotic susceptibility and ultrastructure of Staphylococcus aureus biofilms on surgical suture |
| Q36789133 | Relationship between Antibiotic Resistance, Biofilm Formation, and Biofilm-Specific Resistance in Acinetobacter baumannii |
| Q28543169 | Residual structure of Streptococcus mutans biofilm following complete disinfection favors secondary bacterial adhesion and biofilm re-development |
| Q28305587 | Responses of Pseudomonas aeruginosa to antimicrobials |
| Q96591732 | Responses of freshwater biofilm formation processes (from colonization to maturity) to anatase and rutile TiO2 nanoparticles: Effects of nanoparticles aging and transformation |
| Q34554419 | Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy |
| Q37278886 | Riboswitch control of induction of aminoglycoside resistance acetyl and adenyl-transferases |
| Q42201298 | Role of PBPD1 in stimulation of Listeria monocytogenes biofilm formation by subminimal inhibitory β-lactam concentrations |
| Q26798427 | Role of quorum sensing in bacterial infections |
| Q26801266 | Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs |
| Q93046933 | Ruthenium Chloride-Induced Oxidative Cyclization of Trans-Resveratrol to (±)-ε-Viniferin and Antimicrobial and Antibiofilm Activity Against Streptococcus pneumoniae |
| Q36121146 | S-Nitroso-N-acetylpenicillamine (SNAP) Impregnated Silicone Foley Catheters: A Potential Biomaterial/Device To Prevent Catheter-Associated Urinary Tract Infections |
| Q33625735 | SOS involvement in stress-inducible biofilm formation |
| Q38219786 | SOS, the formidable strategy of bacteria against aggressions. |
| Q35235414 | Scaffold-based anti-infection strategies in bone repair |
| Q24676453 | Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa |
| Q36229074 | Selective pressure of antibiotic pollution on bacteria of importance to public health |
| Q91533101 | Selective pressures during chronic infection drive microbial competition and cooperation |
| Q40058653 | Severity of drug resistance and co-existence of Enterococcus faecalis in diabetic foot ulcer infections |
| Q37406333 | Side effects of antibiotics on genetic variability. |
| Q24644554 | Signals, regulatory networks, and materials that build and break bacterial biofilms |
| Q38205141 | Significance of biofilm for the prosthetic surgeon. |
| Q42032181 | Small lipopeptides possess anti-biofilm capability comparable to daptomycin and vancomycin |
| Q34109642 | Small-molecule modulators of Listeria monocytogenes biofilm development |
| Q35718092 | Socially mediated induction and suppression of antibiosis during bacterial coexistence. |
| Q48150605 | Sodium Lactate Negatively Regulates Shewanella putrefaciens CN32 Biofilm Formation via a Three-Component Regulatory System (LrbS-LrbA-LrbR). |
| Q41062024 | Spatial Organization Plasticity as an Adaptive Driver of Surface Microbial Communities |
| Q38861928 | Specialised metabolites regulating antibiotic biosynthesis in Streptomyces spp. |
| Q40826620 | Streptomyces-derived actinomycin D inhibits biofilm formation by Staphylococcus aureus and its hemolytic activity |
| Q51182470 | Streptomycin favors biofilm formation by altering cell surface properties. |
| Q27660897 | Structural study of TcaR and its complexes with multiple antibiotics from Staphylococcus epidermidis |
| Q27656038 | Structure and mechanism of a bacterial light-regulated cyclic nucleotide phosphodiesterase |
| Q33263149 | Structure-based discovery of inhibitors of the YycG histidine kinase: new chemical leads to combat Staphylococcus epidermidis infections |
| Q57805452 | Structure-guided disruption of the pseudopilus tip complex inhibits the Type II secretion in Pseudomonas aeruginosa |
| Q41786731 | Sub-MIC of antibiotics induced biofilm formation of Pseudomonas aeruginosa in the presence of chlorhexidine |
| Q26747423 | Sub-Optimal Treatment of Bacterial Biofilms |
| Q64921445 | Sub-inhibitory Effects of Antimicrobial Peptides. |
| Q44940903 | Sub-inhibitory concentrations of antibiotics and wastewater influencing biofilm formation and gene expression of multi-resistant Pseudomonas aeruginosa wastewater isolates |
| Q34860393 | Sub-inhibitory concentrations of some antibiotics can drive diversification of Pseudomonas aeruginosa populations in artificial sputum medium |
| Q55109762 | Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation. |
| Q36075849 | Subinhibitory Doses of Aminoglycoside Antibiotics Induce Changes in the Phenotype of Mycobacterium abscessus. |
| Q35677483 | Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity |
| Q35049468 | Subinhibitory concentration of kanamycin induces the Pseudomonas aeruginosa type VI secretion system |
| Q40875296 | Subinhibitory concentrations of metronidazole increase biofilm formation in Clostridium difficile strains |
| Q35097708 | Subinhibitory concentrations of triclosan promote Streptococcus mutans biofilm formation and adherence to oral epithelial cells |
| Q35076815 | Sublethal concentrations of carbapenems alter cell morphology and genomic expression of Klebsiella pneumoniae biofilms |
| Q46312804 | Subminimal inhibitory concentration (sub-MIC) of antibiotic induces electroactive biofilm formation in bioelectrochemical systems. |
| Q28493079 | Substrate specificity and function of acetylpolyamine amidohydrolases from Pseudomonas aeruginosa |
| Q47596328 | Sulfhydryl compounds reduce Staphylococcus aureus biofilm formation by inhibiting PIA biosynthesis |
| Q28659740 | Sympatric inhibition and niche differentiation suggest alternative coevolutionary trajectories among Streptomycetes |
| Q40336024 | Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents |
| Q34584998 | Synthesis and activity of biomimetic biofilm disruptors |
| Q44876039 | Tandem dispersion and killing of bacteria from a biofilm. |
| Q45791598 | Tannin derived materials can block swarming motility and enhance biofilm formation in Pseudomonas aeruginosa |
| Q36457919 | Taxonomy, Physiology, and Natural Products of Actinobacteria |
| Q41656612 | Temperature-dependent control of Staphylococcus aureus biofilms and virulence by thermoresponsive oligo(N-vinylcaprolactam). |
| Q51084165 | Temporal gene-expression in Escherichia coli K-12 biofilms. |
| Q35250893 | The Effect of Sub-MIC β-Lactam Antibiotic Exposure of Pseudomonas aeruginosa Strains from People with Cystic Fibrosis in a Desiccation Survival Model |
| Q92352916 | The Effects of β-Lactam Antibiotics on Surface Modifications of Multidrug-Resistant Escherichia coli: A Multiscale Approach |
| Q40251230 | The Naturally Occurring Host Defense Peptide, LL-37, and Its Truncated Mimetics KE-18 and KR-12 Have Selected Biocidal and Antibiofilm Activities Against Candida albicans, Staphylococcus aureus, and Escherichia coli In vitro. |
| Q47162748 | The Oxidative Stress Agent Hypochlorite Stimulates c-di-GMP Synthesis and Biofilm Formation in Pseudomonas aeruginosa |
| Q28492585 | The PprA-PprB two-component system activates CupE, the first non-archetypal Pseudomonas aeruginosa chaperone-usher pathway system assembling fimbriae |
| Q59113701 | The Promotion of Antibacterial Effects of Ti6Al4V Alloy Modified with TiO2Nanotubes Using a Superoxidized Solution |
| Q91863841 | The Pseudomonas aeruginosa accessory genome elements influence virulence towards Caenorhabditis elegans |
| Q98177595 | The Regulator PltZ Regulates a Putative ABC Transporter System PltIJKNOP of Pseudomonas aeruginosa ATCC 27853 in Response to the Antimicrobial 2,4-Diacetylphloroglucinol |
| Q93189398 | The Supramolecular Self-Assembly of Aminoglycoside Antibiotics and their Applications |
| Q46606846 | The Two-Component Signal Transduction System VxrAB Positively Regulates Vibrio cholerae Biofilm Formation |
| Q92258358 | The Usefulness of Microalgae Compounds for Preventing Biofilm Infections |
| Q35101767 | The antibacterial and anti-biofouling performance of biogenic silver nanoparticles by Lactobacillus fermentum |
| Q35482558 | The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria |
| Q33856134 | The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa |
| Q39367045 | The contribution of Pseudomonas aeruginosa virulence factors and host factors in the establishment of urinary tract infections |
| Q55476956 | The developing premature infant gut microbiome is a major factor shaping the microbiome of neonatal intensive care unit rooms. |
| Q37375780 | The double life of antibiotics. |
| Q40721650 | The effect of alginate lyase on the gentamicin resistance of Pseudomonas aeruginosa in mucoid biofilms. |
| Q40219342 | The effectiveness of anti-biofilm and anti-virulence properties of dihydrocelastrol and dihydrocelastryl diacetate in fighting against methicillin-resistant Staphylococcus aureus. |
| Q40647464 | The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells. |
| Q33711476 | The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin |
| Q36634360 | The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time? |
| Q36020665 | The ferrichrome receptor A as a new target for Pseudomonas aeruginosa virulence attenuation |
| Q36109570 | The icmF3 locus is involved in multiple adaptation- and virulence-related characteristics in Pseudomonas aeruginosa PAO1 |
| Q38050078 | The microbiome in wound repair and tissue fibrosis |
| Q41249257 | The multifaceted roles of antibiotics and antibiotic resistance in nature |
| Q53497754 | The multifaceted roles of the interspecies signalling molecule indole in Agrobacterium tumefaciens. |
| Q35098221 | The prrF-encoded small regulatory RNAs are required for iron homeostasis and virulence of Pseudomonas aeruginosa |
| Q35297286 | The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation |
| Q28082442 | The role of biofilms as environmental reservoirs of antibiotic resistance |
| Q41712008 | The role of the two-component systems Cpx and Arc in protein alterations upon gentamicin treatment in Escherichia coli |
| Q24683150 | The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity |
| Q33828707 | Thiazolidione derivatives targeting the histidine kinase YycG are effective against both planktonic and biofilm-associated Staphylococcus epidermidis |
| Q50077277 | Thiol Starvation induces redox-mediated dysregulation of Escherichia coli biofilm components. |
| Q42031700 | Tight modulation of Escherichia coli bacterial biofilm formation through controlled expression of adhesion factors. |
| Q40119729 | Tobramycin and Amikacin Delay Adhesion and Microcolony Formation in Pseudomonas aeruginosa Cystic Fibrosis Isolates |
| Q33594902 | Tobramycin at subinhibitory concentration inhibits the RhlI/R quorum sensing system in a Pseudomonas aeruginosa environmental isolate |
| Q36575038 | Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System |
| Q64068057 | Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents—How P. aeruginosa Can Escape Antibiotics |
| Q90587533 | Towards Understanding the Molecular Basis of Nitric Oxide-Regulated Group Behaviors in Pathogenic Bacteria |
| Q64059475 | Two Component Regulatory Systems and Antibiotic Resistance in Gram-Negative Pathogens |
| Q96576634 | Ultrastructure imaging of Pseudomonas aeruginosa lawn biofilms and eradication of the tobramycin-resistant variants under in vitro electroceutical treatment |
| Q41869974 | Unpredictable effects of rifampin as an adjunctive agent in elimination of rifampin-susceptible and -resistant Staphylococcus aureus strains grown in biofilms |
| Q36457176 | Update in cystic fibrosis 2005 |
| Q33641535 | Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. |
| Q40137469 | Use of Single-Frequency Impedance Spectroscopy to Characterize the Growth Dynamics of Biofilm Formation in Pseudomonas aeruginosa |
| Q36157314 | Use of β-caryophyllene to combat bacterial dental plaque formation in dogs |
| Q36314952 | Virulence and prodigiosin antibiotic biosynthesis in Serratia are regulated pleiotropically by the GGDEF/EAL domain protein, PigX. |
| Q48632952 | Virulence-targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms |
| Q90682818 | What are the advantages of living in a community? A microbial biofilm perspective! |
| Q39261097 | Workshop report: the 2012 antimicrobial agents in veterinary medicine: exploring the consequences of antimicrobial drug use: a 3-D approach. |
| Q35759645 | YcfR (BhsA) influences Escherichia coli biofilm formation through stress response and surface hydrophobicity. |
| Q33543125 | YfiBNR mediates cyclic di-GMP dependent small colony variant formation and persistence in Pseudomonas aeruginosa |
| Q83673248 | [Antibiotic treatment of nosocomial pneumonia] |
| Q91901915 | [Management of nosocomial pneumonia-state of the art] |
| Q33728575 | dATP/ATP, a multifunctional nucleotide, stimulates bacterial cell lysis, extracellular DNA release and biofilm development |
| Q37984220 | ppGpp: magic beyond RNA polymerase |
Search more.